HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aline Martin Selected Research

Familial Hypophosphatemic Rickets (X-Linked Hypophosphatemia)

3/2011ASARM peptides: PHEX-dependent and -independent regulation of serum phosphate.
4/2008Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Aline Martin Research Topics

Disease

7Chronic Renal Insufficiency
08/2021 - 01/2012
5Hypophosphatemia
01/2020 - 03/2011
5Hyperphosphatemia
12/2019 - 09/2009
4Inflammation (Inflammations)
08/2021 - 01/2012
3Iron Deficiencies
08/2021 - 01/2016
3Hypophosphatemic Rickets
01/2020 - 04/2008
3Hypocalcemia
01/2016 - 01/2012
2Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets)
10/2021 - 01/2020
2Cardiovascular Diseases (Cardiovascular Disease)
12/2019 - 06/2017
2Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
01/2018 - 12/2015
2Familial Hypophosphatemic Rickets (X-Linked Hypophosphatemia)
03/2011 - 04/2008
2Body Weight (Weight, Body)
12/2008 - 07/2007
2Bone Resorption
07/2007 - 08/2005
1Type 2 Diabetes Mellitus (MODY)
08/2021
1Fibrosis (Cirrhosis)
12/2019
1Anemia
12/2019
1Iron-Deficiency Anemia (Anemia, Iron Deficiency)
12/2019
1Proteinuria
12/2019
1Bone Diseases (Bone Disease)
01/2019
1Heart Failure
01/2018
1Critical Illness (Critically Ill)
06/2017
1Albuminuria
01/2017
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2017
1Obesity
01/2016
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2016
1Kidney Diseases (Kidney Disease)
01/2012
1Renal Insufficiency (Renal Failure)
01/2012

Drug/Important Bio-Agent (IBA)

8Fibroblast Growth Factor-23IBA
08/2021 - 01/2012
6Phosphates (Orthophosphate)IBA
08/2021 - 04/2008
4LeptinIBA
01/2016 - 08/2005
3Proteins (Proteins, Gene)FDA Link
10/2021 - 04/2008
2Lipocalin-2IBA
08/2021 - 01/2012
2MineralsIBA
01/2019 - 01/2016
2Hormones (Hormone)IBA
01/2019 - 06/2017
2Messenger RNA (mRNA)IBA
01/2016 - 03/2011
21,25-dihydroxyvitamin DIBA
01/2015 - 01/2012
2hydroxide ionIBA
01/2015 - 12/2013
1Sodium-Glucose Transport ProteinsIBA
08/2021
1Sodium-Glucose Transporter 2 InhibitorsIBA
08/2021
1CateninsIBA
01/2020
1SolutionsIBA
01/2020
1Neutralizing AntibodiesIBA
01/2020
1ferric citrateIBA
12/2019
1Urea (Carbamide)FDA LinkGeneric
01/2018
1NitrogenIBA
01/2018
1Biomarkers (Surrogate Marker)IBA
06/2017
1Angiotensin-Converting Enzyme 2IBA
01/2017
1DNA (Deoxyribonucleic Acid)IBA
01/2017
1Streptozocin (Streptozotocin)FDA Link
01/2017
1LipidsIBA
01/2016
1AdiponectinIBA
01/2016
1IronIBA
01/2016
1Sucrose (Saccharose)IBA
01/2016
1Insulin (Novolin)FDA Link
01/2016
1Type 4 Fibroblast Growth Factor ReceptorIBA
12/2015
125-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)IBA
12/2013
1CalciumIBA
12/2013
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2012
1Transforming Growth Factor beta (TGF-beta)IBA
01/2012
1CollagenIBA
01/2012
1Aspartic Acid (Aspartate)FDA Link
03/2011
1Peptides (Polypeptides)IBA
03/2011
1Serine (L-Serine)FDA Link
03/2011
1Vitamin DFDA LinkGeneric
03/2011
1EndopeptidasesIBA
04/2008
1Insulin-Like Growth Factor I (IGF-1)IBA
07/2007

Therapy/Procedure

2Injections
01/2017 - 01/2016
1Intraventricular Infusions
12/2008